Home
Live Updates
LinKinVax and Inserm Transfert Enter Into an Exclusive Worldwide Licensing Agreement Covering Use of an Innovative Vaccine Platform : comparemela.com
LinKinVax and Inserm Transfert Enter Into an Exclusive Worldwide Licensing Agreement Covering Use of an Innovative Vaccine Platform
LinKinVax, a clinical-stage biotech company, is announcing the signing of an exclusive worldwide licensing agreement with Inserm Transfert to develop a vaccine strategy with an innovative mechanism of
Related Keywords
Paris ,
France General ,
France ,
French ,
Inserm Universit ,
Jacques Auberton Herv ,
Inserm Transfert ,
Corinne Margot ,
Annie Florence Loyer ,
Inserm Transfert Initiative ,
Mondor Institute For Biomedical Research ,
Service Public ,
Research Inserm ,
Vaccine Research Institute Inserm ,
Research Unit ,
Vaccine Research Institute ,
University Of Paris Est Cr ,
Public Service Management Contract ,
Baylor Scott White Research Institute ,
French National Institute Of The Health ,
Dendritic Cells ,
Mondor Institute ,
Biomedical Research ,
Vaccine Research ,
Pascale Aug ,
Executive Management Board ,
Honorary Chairman ,
Yves Levy ,
French National Institute ,
Medical Research ,
Florence Loyer ,
Linkinvax ,
Inserm ,
Transfert ,
Winter ,
Into ,
Exclusive ,
Orldwide ,
Icensing ,
Agreement ,
Covering ,
Nnovative ,
Vaccine ,
Platform ,
comparemela.com © 2020. All Rights Reserved.